glp-1 coverage medicare covers GLP-1s to treat diabetes and some other health conditions, including obstructive sleep apnea and cardiovascular disease, but not obesity obesitymedicine #medicare #glp1 #patientaccess #priorauthorization
Description
Many countries in Europe and the United States have introduced strict policy for obesity drug approval mainly because of safety reasons
The researchers found a lower rate of adverse clinical events in the GLP-1 treated group

When that same excess fat is driving sleep apnea, joint pain, prediabetes, or PCOS, it becomes clinical obesity, a disease causing real harm

While the results in AD models are mixed, with benefits varying between specific models, GLP-1RAs show consistent neuroprotective effects in PD models, protecting dopaminergic neurons and reducing inflammation

The SELECT trial (Semaglutide Effects on Heart Disease and Stroke in Patients with Overweight or Obesity), completed in 2023 with over 17,600 participants, demonstrated a 20% reduction in major adverse cardiovascular events in patients with established cardiovascular disease and overweight or obesity but without diabetes

But can you get your GLP-1 tested